Johnson & Johnson

Following the news that the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC)…

The European Commission is seeking clarification from J&J about the company’s “completely unexpected” announcement of delays…

FDA acting commissioner Janet Woodcock said it expected the pause to be a matter of days, and it was aimed at providing…

India has indicated that any vaccine maker must conduct such a trial for a shot to be considered for its immunisation programme

The vaccine candidate will initially be tested in a small number of adolescents aged 16-17 years

Those countries are Bulgaria, Croatia, Estonia, Latvia and Slovakia. They will also receive their pro-rata share of the total 10…

It had previously said it was developing a second-generation vaccine that would target the variant first identified in South…

Data have demonstrated vaccine protects against COVID-19 related hospitalisation and death in broad geographic regions, including…

If granted conditional marketing authorisation by the EC, the J&J single-shot COVID-19 vaccine will be available in the EU

In J&J’s 44,000-person global trial, the vaccine was found to be 66 per cent effective at preventing moderate-to-severe…